Status:
TERMINATED
Elective Percutaneous Coronary Intervention With or Without Supplemental OXYgen
Lead Sponsor:
Karolinska Institutet
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Supplemental oxygen is frequently used in patients admitted to hospital due to ischemic heart disease. In the setting of suspected myocardial infarction, clinical practice guidelines advocate the use ...
Detailed Description
Aim: The aim of the EPOXY-IMR trial is to evaluate the effect of supplemental oxygen on coronary circulation in the setting of elective coronary angiography and percutaneous coronary intervention (PC...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years of age, AND
- Undergoing elective coronary angiography due to suspected stabile coronary artery disease
- Evidence of moderate (40%-79%) stenosis, requiring further routine assessment with FFR.
- Informed consent
Exclusion
- Acute coronary syndrome or myocardial infarction within 7 days
- Hypoxia with oxygen saturation measured on pulse oximeter \< 90% with the patient breathing air
- Left ventricular hypertrophy on echocardiography (septum \>13mm)
- Asthma (not COPD)
- Advanced AV-block without pacemaker in situ
- Altered conscious state/inability to provide informed consent
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03369184
Start Date
January 1 2018
End Date
August 1 2020
Last Update
October 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stockholm South General Hospital
Stockholm, Sweden, 11883